Literature DB >> 8435563

Prenatal screening for hepatitis B surface antigen. Is universal screening necessary?

B A Morris1, L Sabetti.   

Abstract

Prenatal screening for hepatitis B is now recommended as a universal practice in Canada. This study questions whether that policy should apply outside large urban centres. We studied women delivering babies at the Royal Victoria Hospital in Barrie, Ont. Of 1216 women, results of HBsAg screening were available for 716; only two women, both from a high-risk group, were HBsAg positive. If selective screening is used, physicians must question patients carefully to ensure that women at risk are identified and tested.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435563      PMCID: PMC2379580     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  12 in total

1.  Routine hepatitis screening in adolescent pregnancies: is it cost effective?

Authors:  A M Wetzel; D S Kirz
Journal:  Am J Obstet Gynecol       Date:  1987-01       Impact factor: 8.661

Review 2.  Universal prenatal hepatitis B testing: is it cost-effective?

Authors:  R L Koretz
Journal:  Obstet Gynecol       Date:  1989-11       Impact factor: 7.661

3.  The pregnant hepatitis B carrier: evidence favoring comprehensive antepartum screening.

Authors:  P R Summers; M K Biswas; J G Pastorek; M L Pernoll; L G Smith; B E Bean
Journal:  Obstet Gynecol       Date:  1987-05       Impact factor: 7.661

4.  Screening for hepatitis B among pregnant patients in a rural population.

Authors:  J M Graham; J D Blanco; K P Magee
Journal:  South Med J       Date:  1992-06       Impact factor: 0.954

5.  Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization.

Authors:  C E Stevens; P T Toy; M J Tong; P E Taylor; G N Vyas; P V Nair; M Gudavalli; S Krugman
Journal:  JAMA       Date:  1985 Mar 22-29       Impact factor: 56.272

6.  Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.

Authors:  R P Beasley; L Y Hwang; G C Lee; C C Lan; C H Roan; F Y Huang; C L Chen
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

7.  Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin.

Authors:  H W Reesink; E E Reerink-Brongers; B J Lafeber-Schut; J Kalshoven-Benschop; H G Brummelhuis
Journal:  Lancet       Date:  1979-09-01       Impact factor: 79.321

8.  Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial.

Authors:  R P Beasley; L Y Hwang; C E Stevens; C C Lin; F J Hsieh; K Y Wang; T S Sun; W Szmuness
Journal:  Hepatology       Date:  1983 Mar-Apr       Impact factor: 17.425

Review 9.  Lung defenses against infection: a clinical correlation.

Authors:  S Murphy; A L Florman
Journal:  Pediatrics       Date:  1983-07       Impact factor: 7.124

10.  Is universal screening for hepatitis B infection warranted in all prenatal populations?

Authors:  S S Christian; P Duff
Journal:  Obstet Gynecol       Date:  1989-08       Impact factor: 7.661

View more
  1 in total

1.  Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women.

Authors:  Meenakshi Dawar; David M Patrick; Mark Bigham; Darrel Cook; Mel Krajden; Helen Ng
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.